GILEAD SCIENCES, INC. BRNS Holdings History
GILEAD SCIENCES, INC.'s Barinthus Biotherapeutics PLC Holding Summary
As of 2025-03-31, GILEAD SCIENCES, INC. held 369,855.00 shares of Barinthus Biotherapeutics PLC(BRNS), totaling $359,760.00. This investment constitutes 0.03% of their stock portfolio, and GILEAD SCIENCES, INC. now holds 0.92% of the outstanding Barinthus Biotherapeutics PLC(BRNS) stock.
The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $1.03 for 250,496.00 shares. Based on historical transaction data and BRNS's current price of $1.50, GILEAD SCIENCES, INC.'s estimated gain on his BRNS holdings is $92,298.57, reflecting a 12.83% gain to date.
GILEAD SCIENCES, INC. BRNS ($1.50) Holding Chart
GILEAD SCIENCES, INC. BRNS ($1.50) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
